Accessibility settings

This paper is in the following e-collection/theme issue:

Methods and Feasibility Studies (550) Cost-Effectiveness and Economics (381) Health Services Research (592) Diabetes (288) Diabetic Retinopathy (20) Vulnerable Populations in Health Research (274) Social Determinants of Health (99)

Published on in Vol 14 (2025)

This is a member publication of University of Toronto

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/60488, first published .
Diabetic Retinopathy Screening Among at Risk Populations: Protocol for Distributional Cost-Effectiveness Analysis

Diabetic Retinopathy Screening Among at Risk Populations: Protocol for Distributional Cost-Effectiveness Analysis

Diabetic Retinopathy Screening Among at Risk Populations: Protocol for Distributional Cost-Effectiveness Analysis

Authors of this article:

Aleksandra Stanimirovic1, 2, 3, 4 Author Orcid Image ;   Troy Francis1, 2, 4, 5 Author Orcid Image ;   Sonia Meerai6 Author Orcid Image ;   Suja Mathew1, 4, 5 Author Orcid Image ;   Sarah Ibrahim5, 7, 8 Author Orcid Image ;   James M Bowen1, 2, 3, 4, 5, 9 Author Orcid Image ;   Aleksandra PIkula9, 10, 11 Author Orcid Image ;   Valeria Rac1, 2, 3, 4, 5 Author Orcid Image
Article Authors Cited by (2) Tweetations Metrics

Journals

  1. Nenkova I, Lilova Y, Oscar A, Levi A, Kamusheva M, Petrova G. Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria. British Journal of Clinical Pharmacology 2025 View
  2. Yuan X, Shi J, Wang Q, Hu M. Methodological heterogeneity and equity challenges of distributional cost-effectiveness analysis in healthcare: a systematic review from 2017 to 2025. Archives of Public Health 2026 View